The purpose of the study is to examine the hypothesis test that probiotics will reduce the frequency of exacerbation in patients with COPD.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
probiotic supplement
placebo
OUHSC
Oklahoma City, Oklahoma, United States
COPD exacerbations
The primary end point will be the number of COPD exacerbations.
Time frame: 1 year
Antibiotic Use
Decreased oral or IV antibiotic use
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.